Xueliang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xueliang Wang has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Yanqun Xiao
Department of Molecular Biology, Shanghai Center for Clinical Laboratory, Shanghai, PR China
6 shared publicationsZhongqiang Huang
Department of Molecular Biology, Shanghai Center for Clinical Laboratory, Shanghai 200126, PR China; Shanghai Academy of Experimental Medicine, Shanghai 200126, PR China
6 shared publicationsChunli Shi
Department of Molecular Biology, Shanghai Center for Clinical Laboratory
5 shared publications- Xiaobo Hu
Shanghai Center for Clinical Laboratory, Shanghai, China
5 shared publications Xiaoyu Fan
Department of Molecular Biology, Shanghai Center for Clinical Laboratory, Shanghai 200126, PR China; Shanghai Academy of Experimental Medicine, Shanghai 200126, PR China
5 shared publicationsRan Zhao
Department of Quality Control Material R&D, Shanghai Center for Clinical Laboratory, Shanghai, China
4 shared publications
Latest Publications
- Open Access
- 28 May 2026
- Published by Elsevier in Journal of Clinical Virology
- Vol. 185, 105963
Evaluation of four automated nucleic acid testing systems for the ultrasensitive quantification of hepatitis B virus
- 28 May 2026
- Published by Elsevier in Journal of Clinical Virology
- Vol. 185, 105963
Open AccessEvaluation of four automated nucleic acid testing systems for the ultrasensitive quantification of hepatitis B virus
- Open Access
- 9 March 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1763839
Characterization of a novel composite ICE in Streptococcus agalactiae conferring resistance to macrolides [erm(TR)] and cadmium (cadA)
Background: Macrolide resistance genes ( erm and mef families) and heavy metal resistance genes ( cadA ) are increasingly disseminated among streptococci via diverse mobile genetic elements. Methods: Through whole-genome sequencing of 16 Streptococcus agalactiae isolates resistant to both erythromycin and clindamycin, we identified 19 integrative and conjugative elements (ICEs), a type of self-transfer genetic elements, conferring antibiotic resistance. Among these, a novel composite ICE designated ICE Sag 39 was identified in S. agalactiae Sag 39 through comparative analysis with the NCBI database. Results: ICE Sag 39 measured 113,125 bp in length, and it featured a nested “Russian doll” structure comprising an ICE Sa 2603 family backbone integrated with an internal Tn 1806 -like ICE. The embedded Tn 1806 -like ICE contained four variable regions (VR1-VR4) that serve as insertion hotspots; among these, VR3 and VR4 carry erm (TR) from ICE Sp 2907 and the cadmium resistance gene cadA from an uncharacterized genetic element, respectively. Conjugation and excision assays confirmed that ICE Sag 39 transfers at a frequency of 8.2 × 10 −9 and co-transfers both resistance determinants. Under cadmium stress, transconjugants carrying ICE Sag 39 displayed enhanced growth relative to the recipient. Although the internal Tn 1806 -like ICE was also capable of independent transfer, its efficiency was significantly lower (< 10 −9 ), and its circular form is undetectable by PCR. Database screening identified 199 structurally similar ICEs (ICE Sag 39-like ICE), 62.8% (125/199) of which co-carried erm (TR) and cadA , underscoring the prevalence of this ICE and its associated resistance traits. Conclusions: This study characterizes a new composite ICE and elucidates a modular mechanism that facilitates the assembly and dissemination of resistance genes, thereby promoting bacterial genome diversification.
- 9 March 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1763839
Open AccessCharacterization of a novel composite ICE in Streptococcus agalactiae conferring resistance to macrolides [erm(TR)] and cadmium (cadA)
Background: Macrolide resistance genes ( erm and mef families) and heavy metal resistance genes ( cadA ) are increasingly disseminated among streptococci via diverse mobile genetic elements. Methods: Through whole-genome sequencing of 16 Streptococcus agalactiae isolates resistant to both erythromycin and clindamycin, we identified 19 integrative and conjugative elements (ICEs), a type of self-transfer genetic elements, conferring antibiotic resistance. Among these, a novel composite ICE designated ICE Sag 39 was identified in S. agalactiae Sag 39 through comparative analysis with the NCBI database. Results: ICE Sag 39 measured 113,125 bp in length, and it featured a nested “Russian doll” structure comprising an ICE Sa 2603 family backbone integrated with an internal Tn 1806 -like ICE. The embedded Tn 1806 -like ICE contained four variable regions (VR1-VR4) that serve as insertion hotspots; among these, VR3 and VR4 carry erm (TR) from ICE Sp 2907 and the cadmium resistance gene cadA from an uncharacterized genetic element, respectively. Conjugation and excision assays confirmed that ICE Sag 39 transfers at a frequency of 8.2 × 10 −9 and co-transfers both resistance determinants. Under cadmium stress, transconjugants carrying ICE Sag 39 displayed enhanced growth relative to the recipient. Although the internal Tn 1806 -like ICE was also capable of independent transfer, its efficiency was significantly lower (< 10 −9 ), and its circular form is undetectable by PCR. Database screening identified 199 structurally similar ICEs (ICE Sag 39-like ICE), 62.8% (125/199) of which co-carried erm (TR) and cadA , underscoring the prevalence of this ICE and its associated resistance traits. Conclusions: This study characterizes a new composite ICE and elucidates a modular mechanism that facilitates the assembly and dissemination of resistance genes, thereby promoting bacterial genome diversification.
- Open Access
- 5 February 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (2) , 375
Site-Specific Nested Integration of Tn1806 into ICESa2603-Family Integrative and Conjugative Elements in Streptococcus agalactiae
Composite integrative and conjugative elements (ICEs) frequently mediate the co-transfer of multiple antibiotic resistance genes during horizontal gene transfer, but their formation mechanisms remain unclear. This study investigated the site-specific integration of Tn1806 into ICESa2603-family ICEs in Streptococcus agalactiae by conjugation experiments. PCR screening of 161 S. agalactiae clinical isolates identified potential Tn1806-like ICE carriers; whole-genome sequencing was performed to further characterize the macrolide-resistance isolates from this group. PCR detection resulted in 24 carrying Tn1806-like ICEs being found, five of which were macrolide-resistant. Genomic analysis for these five revealed distinct Tn1806-like ICEs (ICESag16, ICESag57, ICESag139, ICESag167, and ICESag220), three of which were found nested within another ICE (ICESpy009, an ICESa2603-family ICE). Conjugation experiments confirmed ICESag167 could integrate into the snf2 (methyltransferase containing a SNF2 helicase domain) of ICESpy009 in recipient cells, generating a composite ICE. Re-conjugation verified the transferability of composite ICE at low frequencies (8.63 × 10−8), during which some nested ICESag167 were excised and transferred independently. This work provides first experimental evidence supporting Tn1806 nesting within another ICE as a mechanism for resistance accumulation and mobile element evolution in S. agalactiae. The spread of such composite ICEs may confer multiple forms of resistance to new hosts, challenging infection treatment and raising public health concerns.
- 5 February 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (2) , 375
Open AccessSite-Specific Nested Integration of Tn1806 into ICESa2603-Family Integrative and Conjugative Elements in Streptococcus agalactiae
Composite integrative and conjugative elements (ICEs) frequently mediate the co-transfer of multiple antibiotic resistance genes during horizontal gene transfer, but their formation mechanisms remain unclear. This study investigated the site-specific integration of Tn1806 into ICESa2603-family ICEs in Streptococcus agalactiae by conjugation experiments. PCR screening of 161 S. agalactiae clinical isolates identified potential Tn1806-like ICE carriers; whole-genome sequencing was performed to further characterize the macrolide-resistance isolates from this group. PCR detection resulted in 24 carrying Tn1806-like ICEs being found, five of which were macrolide-resistant. Genomic analysis for these five revealed distinct Tn1806-like ICEs (ICESag16, ICESag57, ICESag139, ICESag167, and ICESag220), three of which were found nested within another ICE (ICESpy009, an ICESa2603-family ICE). Conjugation experiments confirmed ICESag167 could integrate into the snf2 (methyltransferase containing a SNF2 helicase domain) of ICESpy009 in recipient cells, generating a composite ICE. Re-conjugation verified the transferability of composite ICE at low frequencies (8.63 × 10−8), during which some nested ICESag167 were excised and transferred independently. This work provides first experimental evidence supporting Tn1806 nesting within another ICE as a mechanism for resistance accumulation and mobile element evolution in S. agalactiae. The spread of such composite ICEs may confer multiple forms of resistance to new hosts, challenging infection treatment and raising public health concerns.
- 17 December 2025
- Published by Elsevier in Journal of Clinical Virology
- Vol. 182, 105907
External quality assessment for molecular detection of multiple respiratory pathogens in China
- 17 December 2025
- Published by Elsevier in Journal of Clinical Virology
- Vol. 182, 105907
External quality assessment for molecular detection of multiple respiratory pathogens in China
- 19 November 2025
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 418 (3) , 883-892
Establishment and characterization of a genomic DNA reference material for Group B Streptococcus detection
Group B Streptococcus (GBS) is a leading cause of maternal and neonatal morbidity and mortality. While molecular assays, like nucleic acid amplification tests, are widely used for GBS detection, their accuracy depends on reliable reference standards. We developed a DNA reference material (RM) for GBS from genomic DNA extracted from reference strain ATCC® 13813™. This RM was quantified using droplet digital PCR and exhibited excellent homogeneity and stability. The certified value of the RM, determined through a multi-center collaborative study, was established as \(\left(7.53\;\pm\;0.48\right)\;\times\;10^3\;\mathrm{copies}/\mu L\), where the uncertainty represents the expanded uncertainty. We further applied the RM to assess the analytical performance of three commercial GBS detection kits. None of the kits consistently achieved their claimed limits of detection, a discrepancy that could lead to false-negative results and subsequent misdiagnosis or inappropriate treatment. Clinical validation confirmed the stability and suitability of the GBS DNA RM for clinical application. The establishment of this GBS DNA RM provides a reliable tool for validating commercial diagnostic kits and platforms, thereby improving the accuracy and reliability of GBS nucleic acid detection. Graphical Abstract- 19 November 2025
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 418 (3) , 883-892
Establishment and characterization of a genomic DNA reference material for Group B Streptococcus detection
Group B Streptococcus (GBS) is a leading cause of maternal and neonatal morbidity and mortality. While molecular assays, like nucleic acid amplification tests, are widely used for GBS detection, their accuracy depends on reliable reference standards. We developed a DNA reference material (RM) for GBS from genomic DNA extracted from reference strain ATCC® 13813™. This RM was quantified using droplet digital PCR and exhibited excellent homogeneity and stability. The certified value of the RM, determined through a multi-center collaborative study, was established as \(\left(7.53\;\pm\;0.48\right)\;\times\;10^3\;\mathrm{copies}/\mu L\), where the uncertainty represents the expanded uncertainty. We further applied the RM to assess the analytical performance of three commercial GBS detection kits. None of the kits consistently achieved their claimed limits of detection, a discrepancy that could lead to false-negative results and subsequent misdiagnosis or inappropriate treatment. Clinical validation confirmed the stability and suitability of the GBS DNA RM for clinical application. The establishment of this GBS DNA RM provides a reliable tool for validating commercial diagnostic kits and platforms, thereby improving the accuracy and reliability of GBS nucleic acid detection. Graphical Abstract- 29 September 2025
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 64 (3) , 609-616
Small-scale external quality assessment of methylated SHOX2 and RASSF1A detection in China: findings from 2023–2024
Objectives: DNA methylation in short homeobox gene 2 ( SHOX2 ) and RAS association domain family protein 1 ( RASSF1A ) shows significant auxiliary diagnostic value for early-stage lung cancer. However, the detection accuracy is frequently compromised because of the complexity of the analytical procedures. This pilot external quality assessment (EQA) study evaluated the performance of methylated SHOX2 ( mSHOX2 ) and methylated RASSF1A ( mRASSF1A ) detection across clinical laboratories in China. Methods: A sample panel was prepared containing two mSHOX2 -positive samples, one mRASSF1A -positive sample, one mSHOX2 and mRASSF1A double-positive sample, and one negative sample. The panel was randomly coded and distributed to clinical laboratories for mSHOX2 and mRASSF1A detection in 2023 and 2024. The returned results were compared and scored to evaluate laboratory performance. Results: The sample panel demonstrated sufficient stability and applicability. Results were collected from 21 laboratories in 2023 and 29 laboratories in 2024. Approximately 90.5 % (19/21) and 75.9 % (22/29) laboratories achieved correct results in 2023 and 2024, respectively. Out of the 105 results in 2023 and 145 results in 2024, 1 false negative and 3 false positives were observed in 2023 and 6 false negatives and 12 false positives in 2024. Conclusions: This two-round EQA study in China emphasizes the need for improvement in the performance of mSHOX2 and mRASSF1A methylation detection. These results underscore the critical role of EQA schemes in monitoring and improving the detection quality in clinical laboratories. To address the challenges in mSHOX2 and mRASSF1A detection, targeted recommendations are proposed to enhance detection accuracy and reliability.
- 29 September 2025
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 64 (3) , 609-616
Small-scale external quality assessment of methylated SHOX2 and RASSF1A detection in China: findings from 2023–2024
Objectives: DNA methylation in short homeobox gene 2 ( SHOX2 ) and RAS association domain family protein 1 ( RASSF1A ) shows significant auxiliary diagnostic value for early-stage lung cancer. However, the detection accuracy is frequently compromised because of the complexity of the analytical procedures. This pilot external quality assessment (EQA) study evaluated the performance of methylated SHOX2 ( mSHOX2 ) and methylated RASSF1A ( mRASSF1A ) detection across clinical laboratories in China. Methods: A sample panel was prepared containing two mSHOX2 -positive samples, one mRASSF1A -positive sample, one mSHOX2 and mRASSF1A double-positive sample, and one negative sample. The panel was randomly coded and distributed to clinical laboratories for mSHOX2 and mRASSF1A detection in 2023 and 2024. The returned results were compared and scored to evaluate laboratory performance. Results: The sample panel demonstrated sufficient stability and applicability. Results were collected from 21 laboratories in 2023 and 29 laboratories in 2024. Approximately 90.5 % (19/21) and 75.9 % (22/29) laboratories achieved correct results in 2023 and 2024, respectively. Out of the 105 results in 2023 and 145 results in 2024, 1 false negative and 3 false positives were observed in 2023 and 6 false negatives and 12 false positives in 2024. Conclusions: This two-round EQA study in China emphasizes the need for improvement in the performance of mSHOX2 and mRASSF1A methylation detection. These results underscore the critical role of EQA schemes in monitoring and improving the detection quality in clinical laboratories. To address the challenges in mSHOX2 and mRASSF1A detection, targeted recommendations are proposed to enhance detection accuracy and reliability.
- 13 September 2025
- Published by Elsevier in Bioelectrochemistry
- Vol. 168, 109108
An electrochemical biosensor for immobilization coupling and quantifying exosomes based on a UiO-66 metal−organic framework
- 13 September 2025
- Published by Elsevier in Bioelectrochemistry
- Vol. 168, 109108
An electrochemical biosensor for immobilization coupling and quantifying exosomes based on a UiO-66 metal−organic framework
- Open Access
- 28 March 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1529336
Development and validation of an automated and high-throughput quadruplex RT–ddPCR assay for the detection of influenza A, influenza B, respiratory syncytial virus, and SARS-CoV-2
The main detection method for viral respiratory infections is reverse transcription polymerase chain reaction (RT–PCR), but it is susceptible to sample inhibitors and relies on a standard curve and subjective thresholds to quantify nucleic acid targets. However, droplet digital PCR (ddPCR), the third generation of PCR with higher sensitivity and accuracy, is an effective tool for the detection and absolute quantification of respiratory viruses. In this study, we introduced AHQR–ddPCR, which is an automated and high-throughput quadruplex reverse transcription ddPCR assay based on the QX ONE platform for the detection of influenza A, influenza B, respiratory syncytial virus, and SARS-CoV-2 in a single reaction. The AHQR–ddPCR assay had analytical sensitivity as low as 0.65–0.78 copies/μL for four respiratory viruses, and exhibited excellent analytical specificity, intraassay and interassay precision, and a wide linear range for each viral target. The results in clinical samples showed that the assay had good concordance and better diagnostic sensitivity compared to RT-PCR. In short, the highly sensitive and absolutely quantitative AHQR–ddPCR assay has excellent analytical and clinical performance, and the advantage of detecting weakly positive samples, which can effectively reduce false-negative results and is a powerful complement to RT–PCR. In addition, it has great value for virology research and the development of automated molecular assays.
- 28 March 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1529336
Open AccessDevelopment and validation of an automated and high-throughput quadruplex RT–ddPCR assay for the detection of influenza A, influenza B, respiratory syncytial virus, and SARS-CoV-2
The main detection method for viral respiratory infections is reverse transcription polymerase chain reaction (RT–PCR), but it is susceptible to sample inhibitors and relies on a standard curve and subjective thresholds to quantify nucleic acid targets. However, droplet digital PCR (ddPCR), the third generation of PCR with higher sensitivity and accuracy, is an effective tool for the detection and absolute quantification of respiratory viruses. In this study, we introduced AHQR–ddPCR, which is an automated and high-throughput quadruplex reverse transcription ddPCR assay based on the QX ONE platform for the detection of influenza A, influenza B, respiratory syncytial virus, and SARS-CoV-2 in a single reaction. The AHQR–ddPCR assay had analytical sensitivity as low as 0.65–0.78 copies/μL for four respiratory viruses, and exhibited excellent analytical specificity, intraassay and interassay precision, and a wide linear range for each viral target. The results in clinical samples showed that the assay had good concordance and better diagnostic sensitivity compared to RT-PCR. In short, the highly sensitive and absolutely quantitative AHQR–ddPCR assay has excellent analytical and clinical performance, and the advantage of detecting weakly positive samples, which can effectively reduce false-negative results and is a powerful complement to RT–PCR. In addition, it has great value for virology research and the development of automated molecular assays.
- 1 October 2024
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1336, 343295
The current status and future prospects of CRISPR-based detection of monkeypox virus: A review
- 1 October 2024
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1336, 343295
The current status and future prospects of CRISPR-based detection of monkeypox virus: A review
- Open Access
- 10 May 2023
- Published by Wiley in Cancer Medicine
- Vol. 12 (13) , 14636-14645
Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19‐9, gender, and age
Background: Conventional blood and stool tests are normally used for early screening of colorectal cancer (CRC) but the accuracy and efficiency remain to be improved. Recent findings suggest Fusobacterium nucleatum to be a biomarker for CRC. This study evaluated the role of F. nucleatum and developed CRC diagnostic models by combining F. nucleatum with fecal occult blood (FOB), transferrin (TRF), carcinoembryonic antigen (CEA), carbohydrate antigen 19‐9 (CA19‐9), gender, and age.Materials and Methods: Candidates including 71 healthy individuals and 59 CRC patients were recruited. Abundance of F. nucleatum in stool or tissue samples was measured by quantitative real‐time PCR. CEA, CA19‐9, TRF, and FOB were measured in parallel. These biomarkers together with genders and ages were the seven parameters used to develop CRC diagnostic models. Ten different machine learning algorithms were tested to achieve the best performance.Results: Fecal F. nucleatum abundance was found significantly higher in CRC group compared to healthy group (p = 0.0005). Among the CRC patients, F. nucleatum abundance in tumor tissue was significantly higher than that in paracancerous tissue (p = 0.0087). CRC diagnostic models using different parameters were generated based on Logistic Regression algorithm, which showed good performance. The area under the curve (AUC) score of fecal F. nucleatum as the single diagnostic biomarker was 0.68 while the accuracy was 0.56. The diagnostic performance was obviously improved with the highest AUC (0.93) and accuracy (0.87) achieved when using all the 7 clinical parameters. The combination F. nucleatum + FOB + gender + age had the second highest AUC (0.92) and accuracy (0.85). A more utilitarian model using F. nucleatum + FOB showed relatively high AUC at 0.86 and accuracy at 0.81.Conclusions: F. nucleatum is valuable for CRC diagnosis. Combination of different clinical parameters could significantly improve CRC diagnostic performance. The combination F. nucleatum + FOB + gender + age may be an effective and noninvasive method for clinical application.
- 10 May 2023
- Published by Wiley in Cancer Medicine
- Vol. 12 (13) , 14636-14645
Open AccessImproved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19‐9, gender, and age
Background: Conventional blood and stool tests are normally used for early screening of colorectal cancer (CRC) but the accuracy and efficiency remain to be improved. Recent findings suggest Fusobacterium nucleatum to be a biomarker for CRC. This study evaluated the role of F. nucleatum and developed CRC diagnostic models by combining F. nucleatum with fecal occult blood (FOB), transferrin (TRF), carcinoembryonic antigen (CEA), carbohydrate antigen 19‐9 (CA19‐9), gender, and age.Materials and Methods: Candidates including 71 healthy individuals and 59 CRC patients were recruited. Abundance of F. nucleatum in stool or tissue samples was measured by quantitative real‐time PCR. CEA, CA19‐9, TRF, and FOB were measured in parallel. These biomarkers together with genders and ages were the seven parameters used to develop CRC diagnostic models. Ten different machine learning algorithms were tested to achieve the best performance.Results: Fecal F. nucleatum abundance was found significantly higher in CRC group compared to healthy group (p = 0.0005). Among the CRC patients, F. nucleatum abundance in tumor tissue was significantly higher than that in paracancerous tissue (p = 0.0087). CRC diagnostic models using different parameters were generated based on Logistic Regression algorithm, which showed good performance. The area under the curve (AUC) score of fecal F. nucleatum as the single diagnostic biomarker was 0.68 while the accuracy was 0.56. The diagnostic performance was obviously improved with the highest AUC (0.93) and accuracy (0.87) achieved when using all the 7 clinical parameters. The combination F. nucleatum + FOB + gender + age had the second highest AUC (0.92) and accuracy (0.85). A more utilitarian model using F. nucleatum + FOB showed relatively high AUC at 0.86 and accuracy at 0.81.Conclusions: F. nucleatum is valuable for CRC diagnosis. Combination of different clinical parameters could significantly improve CRC diagnostic performance. The combination F. nucleatum + FOB + gender + age may be an effective and noninvasive method for clinical application.